UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019820
Receipt number R000022898
Scientific Title Efficacy of inhaled HYdrogen on neurological outcome following BRain Ischemia During post-cardiac arrest care (Phase II, multicenter, prospective, randomized, double-blinded, placebo-controlled trial)
Date of disclosure of the study information 2016/01/01
Last modified on 2023/11/02 19:01:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of inhaled HYdrogen on neurological outcome following BRain Ischemia During post-cardiac arrest care (Phase II, multicenter, prospective, randomized, double-blinded, placebo-controlled trial)

Acronym

HYBRID II trial

Scientific Title

Efficacy of inhaled HYdrogen on neurological outcome following BRain Ischemia During post-cardiac arrest care (Phase II, multicenter, prospective, randomized, double-blinded, placebo-controlled trial)

Scientific Title:Acronym

HYBRID II trial

Region

Japan


Condition

Condition

post cardiac arrest syndrome

Classification by specialty

Medicine in general Cardiology Emergency medicine
Intensive care medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To test the efficacy and safety of hydrogen inhalation for patient with post cardiac arrest syndrome

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Rate of favorable neurological outcome (Cerebral Performance Category (CPC) 1 or 2) at 90 days

Key secondary outcomes

1. Survival rate at 90 days
2. Survival time during 90 days
3. Modified Rankin Scale (mRS), Glasgow coma scale (GCS), and Mini-Mental State Exam (MMSE) at 90 days


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

2%hydrogen+oxygen

Interventions/Control_2

oxygen

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Age of 20 to 80 years.
2. Achieved return of spontaneous circulation irrespective of initial cardiac rhythm after out-of-hospital cardiac arrest.
3. Cardiac arrest of a presumed cardiac cause.
4. Sustained coma (Glasgow Coma Scale less than 8) on admission.
5. Systolic blood pressure equal to or greater than 80 mmHg irrespective of fluid loading, vasopressor and/or inotropic medication.
6. Informed consent obtained from patient's next of kin.
7. Possible to receive gas inhalation less than 6 hours after return of spontaneous circulation.

Key exclusion criteria

1. Known pre-arrest cerebral performance category (CPC) 3 or 4.
2. Known limitations in therapy and do not resuscitate order.
3. Cardiac arrest due to trauma, strangulation, intracranial hemorrhage, subarachnoid hemorrhage, cerebral infarction, acute aortic dissection, terminal cancer, or intoxication.
4. Oxygen saturation of less than 94% with 50% oxygen inhalation and adequate positive end-expiratory pressure.
5. Pregnancy.
6. Cardiopulmonary bypass use.
7. Determined as being inappropriate for the study by site investigators .

Target sample size

360


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masaru Suzuki

Organization

Keio University School of Medicine

Division name

Emergency and critical Care Medicine

Zip code


Address

35 Shinanomachi Shinjuku-ku Tokyo, Japan

TEL

+81-3-3225-1323

Email

suzuki@a2.keio.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomoyoshi Tamura

Organization

Keio University School of Medicine

Division name

Emergency and critical Care Medicine

Zip code


Address

35 Shinanomachi Shinjuku-ku Tokyo, Japan

TEL

+81-3-3225-1323

Homepage URL


Email

tomoyoshitamura@keio.jp


Sponsor or person

Institute

Keio University School of Medicine, Department of Emergency and Critical Care Medicine

Institute

Department

Personal name



Funding Source

Organization

Taiyo Nippon Sanso Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 09 Month 28 Day

Date of IRB

2015 Year 11 Month 17 Day

Anticipated trial start date

2017 Year 02 Month 01 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 17 Day

Last modified on

2023 Year 11 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022898


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name